How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?
Saved in:
| Title: | How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome? |
|---|---|
| Authors: | Paz-Graniel, Indira (AUTHOR), Babio, Nancy (AUTHOR), Nishi, Stephanie K. (AUTHOR), Martínez-González, Miguel Ángel (AUTHOR), Corella, Dolores (AUTHOR), Fitó, Montserrat (AUTHOR), Martínez, Alfredo (AUTHOR), Alonso-Gómez, Ángel M. (AUTHOR), Wärnberg, Julia (AUTHOR), Vioque, Jesús (AUTHOR), Romaguera, Dora (AUTHOR), López-Miranda, José (AUTHOR), Estruch, Ramon (AUTHOR), Tinahones, Francisco J. (AUTHOR), Santos-Lozano, José Manuel (AUTHOR), Serra-Majem, J. Luís (AUTHOR), Bueno-Cavanillas, Aurora (AUTHOR), Tur, Josep A. (AUTHOR), Sánchez, Vicente Martín (AUTHOR), Pintó, Xavier (AUTHOR) |
| Source: | Depression & Anxiety (1091-4269). 7/14/2023, p1-9. 9p. 1 Chart, 1 Graph. |
| Subjects: | Older people, COVID-19 pandemic, Metabolic syndrome, Symptoms, Analysis of covariance |
| Geographic Terms: | Spain |
| Abstract: | Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants (men = 53.9 %; mean age = 64.9 ± 4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P < 0.001); a nonsignificantly larger decrease was observed in participants allocated in the low-lockdown category (low: -0.59 (-0.95, -0.23), high: -0.43 (-0.67, -0.19)). Similar decreases in depression symptomatology were found for the physical environment dimension. The post- and prelockdown phase BDI-II scores were roughly similar. Conclusions. The COVID-19 pandemic lockdown was associated with a decrease in depressive symptomatology that returned to prelockdown levels after the lockdown. The degree of lockdown was not associated with depressive symptomatology. The potential preventive role of the physical environment and social interactions on mental disorders during forced home lockdown should be further studied. This trial is registered with ISRCTN89898870. Retrospectively registered on 24 July 2014. [ABSTRACT FROM AUTHOR] |
| Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
